SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is experiencing significant market volatility after news of a proposed near-flat Medicare Advantage payment rate increase for 2027, a move impacting the broader health insurance sector. This regulatory headwind has sparked a community debate, with many investors viewing the sharp decline as an overreaction and a long-term buying opportunity, while others express caution regarding future margins and growth prospects.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending following its selection for the Missile Defense Agency's $151 billion multi-vendor SHIELD IDIQ contract, connected to the "Golden Dome" initiative. The community is actively discussing the immense revenue potential from this award, even if only a fraction is realized, alongside significant short interest contributing to speculation of a potential squeeze within the robust space and defense sector.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is actively trending ahead of its anticipated Q4 earnings, with investors focused on robust commercial aircraft deliveries
as its highest in several years
and significant new orders, including surpassing Airbus in net sales for the first time since 2018. The community is debating whether a strong operational outlook and production ramp-up can extend its recent rally, while others remain cautious that positive developments might already be priced in.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit (RDDT) is seeing heavy market conversation and notable price swings following reports that YouTube is now a primary data source for AI models, alongside a recent bearish analyst sentiment on its ad business. Investor sentiment is highly polarized, with discussions ranging from concerns over stock performance and insider sales to arguments for long-term value based on its unique content for AI training and anticipation of upcoming earnings. Additionally, broader regulatory proposals in regions like Europe and Australia concerning youth social media usage are creating sector-wide uncertainty.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending after its latest earnings report, which highlighted strong full-year revenue and an optimistic 2026 outlook for demand and profitability, despite a quarterly earnings miss attributed to significant operational disruptions. Investors are debating the airline's resilience and potential for an improved earnings phase, while also observing the broader sector's sensitivity to travel demand and ongoing operational factors.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending amid excitement for its advancements in dual-platform annealing and gate-model quantum technologies, following a significant acquisition and new defense collaborations. The community is sharply divided, with bulls touting the company's perceived leadership and future potential, while bears highlight concerns over valuation, insider selling, and dilution, often alleging market manipulation.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is actively trending after the FDA lifted a clinical hold on its MAGNITUDE-2 Phase 3 trial, igniting widespread bullish sentiment across the community. Investors are keenly discussing the potential for a significant short squeeze, fueled by substantial short interest and consistent accumulation by prominent funds. This positive development, coupled with confidence that the prior patient event was unrelated to the therapy, is driving expectations for a strong rebound in the gene-editing sector.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending due to proposed near-flat Medicare Advantage rates for 2027 and a recent lawsuit loss concerning Medicare bonus payment cuts, significantly impacting market sentiment across the managed care sector. The community is actively debating whether these policy and legal developments signal a fundamental repricing of regulatory risk, or if the current declines are an overreaction. This situation highlights widespread concerns about future margins and growth for companies heavily reliant on Medicare Advantage plans.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending following strong quarterly results and an upbeat outlook, driven by significant cost-reduction strategies and a strategic pivot towards higher-margin business. The community is actively discussing these efficiency gains as a potential inflection point for sustained growth and margin expansion, reassessing its position within the logistics sector and appreciating its consistent dividend.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as the broader healthcare insurance sector reacts sharply to a proposed minimal increase in Medicare Advantage payment rates for 2027. This update, significantly below market expectations, is fueling widespread concern about margin pressure and regulatory risk across health insurers, leading to a notable sector-wide sell-off. While some investors debate if CVS's diversified model offers a buffer, the community is actively discussing the impact, with many viewing it as a "blood bath" and others seeking potential long-term buying opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PTHS Great read. 

Summary

Pelthos Pharmaceuticals has launched Zelsuvmi, the first at-home FDA-approved treatment for molluscum contagiosum, showing strong initial sales growth.

PTHS reported $7.1 million net revenue in its first commercialization quarter, prompting an expansion of its sales force.

The company targets breakeven by end-2026, with peak revenue projections of $175 million likely conservative given rapid prescription uptake and market size.

Recent acquisition of Xepi and a robust pipeline add to growth potential; I am bullish on PTHS based on early results and market opportunity.

Mateo

Audrey

$PTHS Very nice article!

Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely https://seekingalpha.com/article/4849084-pelthos-pharmaceuticals-strong-start-with-zelsuvmi-continued-sales-growth-likely

StockTwits For Android 

Pelthos Therapeutics Inc.

Jwa68

 Great read. 

Summary

Pelthos Pharmaceuticals has launched Zelsuvmi, the first at-home FDA-approved treatment for molluscum contagiosum, showing strong initial sales growth.

PTHS reported $7.1 million net revenue in its first commercialization quarter, prompting an expansion of its sales force.

The company targets breakeven by end-2026, with peak revenue projections of $175 million likely conservative given rapid prescription uptake and market size.

Recent acquisition of Xepi and a robust pipeline add to growth potential; I am bullish on PTHS based on early results and market opportunity.